BioCentury
ARTICLE | Finance

AurorA debuts to back early-stage European biotechs

February 12, 2020 10:54 PM UTC
Updated on Feb 13, 2020 at 9:53 PM UTC

A new Europe-focused investment vehicle has launched with €10 million in backing from two Italian biopharmas.

AurorA Science will be managed by AurorA-TT, a tech transfer company founded in 2017 and led by co-founder, Chairman and Managing Partner Guido Guidi. Guidi was previously head of pharma region Europe and head of oncology Europe at Swiss pharma Novartis AG (NYSE:NVS; SIX:NOVN)...



Access The Full Article